HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chao Zhou Selected Research

Coronary Disease (Coronary Heart Disease)

2/2021[Research Status and Hot Trends in Atherosclerosis Genomics between 2010 and 2019].
3/2018Chinese patent medicine Xin-Ke-Shu inhibits Ca2+ overload and dysfunction of fatty acid β-oxidation in rats with myocardial infarction induced by LAD ligation.
1/2016Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca(2+) overloading and metabolic alternations in isoproterenol-induced myocardial infarction rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chao Zhou Research Topics

Disease

71Neoplasms (Cancer)
01/2024 - 05/2005
18Breast Neoplasms (Breast Cancer)
07/2023 - 09/2007
17Schizophrenia (Dementia Praecox)
04/2024 - 10/2018
16Inflammation (Inflammations)
02/2024 - 01/2008
11Hypoxia (Hypoxemia)
01/2024 - 11/2007
11COVID-19
12/2023 - 01/2020
9Lung Neoplasms (Lung Cancer)
09/2023 - 02/2013
8Adenocarcinoma of Lung
04/2024 - 01/2018
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 03/2020
8Dupuytren Contracture (Dupuytrens Contracture)
12/2018 - 07/2015
7Infections
01/2024 - 12/2015
7Neoplasm Metastasis (Metastasis)
05/2022 - 04/2016
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2018
7Carcinogenesis
01/2021 - 10/2013
6Cognitive Dysfunction
04/2024 - 01/2018
6Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 01/2018
6Brain Injuries (Brain Injury)
02/2024 - 01/2018
6Carcinoma (Carcinomatosis)
01/2024 - 04/2016
6Pain (Aches)
01/2023 - 02/2012
6Traumatic Brain Injuries (Traumatic Brain Injury)
01/2023 - 12/2020
5Wounds and Injuries (Trauma)
01/2024 - 01/2022
5Esophageal Squamous Cell Carcinoma
01/2024 - 01/2020
5Nasopharyngeal Carcinoma
11/2023 - 11/2013
5Stomach Neoplasms (Stomach Cancer)
01/2022 - 04/2016
5Myocardial Infarction
02/2021 - 01/2016
5Contracture
12/2018 - 07/2015
4Necrosis
01/2024 - 01/2018
4Mitochondrial Diseases (Mitochondrial Disease)
09/2023 - 02/2017
4Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2023 - 01/2018
4Triple Negative Breast Neoplasms
07/2023 - 01/2019
4Fibrosis (Cirrhosis)
05/2023 - 10/2013
4Disease Progression
11/2022 - 12/2014
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019 - 01/2014
3Stroke (Strokes)
02/2024 - 10/2021
3Ischemic Stroke
02/2024 - 10/2021
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2024 - 04/2009
3Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 01/2021
3Glioma (Gliomas)
01/2024 - 09/2015
3Pneumonia (Pneumonitis)
01/2024 - 06/2018
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2023 - 06/2018
3Squamous Cell Carcinoma of Head and Neck
02/2023 - 01/2018
3Heart Failure
01/2023 - 03/2010
3Esophageal Neoplasms (Esophageal Cancer)
05/2022 - 01/2018
3Coronary Disease (Coronary Heart Disease)
02/2021 - 01/2016
3Atherosclerosis
02/2021 - 01/2021
3Dysbiosis
01/2021 - 01/2017
3Colitis
06/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

27Biomarkers (Surrogate Marker)IBA
04/2024 - 10/2014
17Proteins (Proteins, Gene)FDA Link
09/2023 - 10/2013
12MicroRNAs (MicroRNA)IBA
01/2022 - 10/2014
10diazonaphthalenedisulfonic acid (NDS)IBA
04/2024 - 10/2018
10Messenger RNA (mRNA)IBA
10/2023 - 10/2013
9Long Noncoding RNAIBA
12/2023 - 01/2018
7Oxygen (Dioxygen)IBA
01/2024 - 09/2006
6Lysine (L-Lysine)FDA Link
01/2023 - 01/2016
6ErbB Receptors (EGF Receptor)IBA
11/2022 - 01/2015
6Histones (Histone)IBA
07/2022 - 09/2015
5Biocompatible Materials (Biomaterials)IBA
01/2024 - 11/2019
5HydrogelsIBA
12/2023 - 11/2019
5RNA (Ribonucleic Acid)IBA
08/2023 - 01/2018
5CholesterolIBA
01/2023 - 01/2013
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2021 - 01/2019
5CytokinesIBA
09/2020 - 08/2013
4Antipsychotic Agents (Antipsychotics)IBA
01/2024 - 01/2021
4AntigensIBA
01/2024 - 01/2022
4mRNA VaccinesIBA
12/2023 - 01/2020
4Small Interfering RNA (siRNA)IBA
08/2023 - 04/2016
4LigandsIBA
01/2023 - 04/2020
4Tyrosine Kinase InhibitorsIBA
11/2022 - 01/2015
4Peptides (Polypeptides)IBA
08/2020 - 01/2017
4Hemoglobins (Hemoglobin)IBA
05/2010 - 05/2005
3CateninsIBA
09/2023 - 01/2020
3Cisplatin (Platino)FDA LinkGeneric
09/2023 - 11/2019
3Immune Checkpoint InhibitorsIBA
01/2023 - 01/2022
3Glucose (Dextrose)FDA LinkGeneric
01/2023 - 09/2013
3Butyrates (Butyrate)IBA
01/2023 - 01/2020
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2023 - 01/2019
3Volatile Fatty AcidsIBA
01/2023 - 01/2020
3icotinibIBA
11/2022 - 01/2015
3ArsenicIBA
08/2022 - 02/2013
3Neuroprotective AgentsIBA
03/2022 - 04/2018
3VaccinesIBA
01/2022 - 01/2020
3Fatty Acids (Saturated Fatty Acids)IBA
06/2021 - 03/2018
3Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 01/2017
3InterleukinsIBA
12/2020 - 12/2015
3Bile Acids and Salts (Bile Acids)IBA
12/2020 - 01/2016
3IntegrinsIBA
08/2020 - 01/2019
3Dextrans (Dextran)FDA Link
06/2020 - 01/2019

Therapy/Procedure

28Therapeutics
12/2024 - 11/2006
10Radiotherapy
01/2024 - 11/2006
7Fasciotomy
12/2018 - 07/2015
6Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2023 - 07/2009
5Immunotherapy
01/2024 - 01/2021
5Drug Therapy (Chemotherapy)
09/2023 - 01/2018
5Radiofrequency Ablation
01/2019 - 01/2009
4Neoadjuvant Therapy
01/2024 - 09/2007
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2023 - 11/2013
4Aftercare (After-Treatment)
03/2021 - 09/2006
3Lasers (Laser)
03/2022 - 07/2008
3Catheters
01/2022 - 10/2017